Industry: Service & Software
Published Date: 2024-01-24
Pages: 106 Pages
Report ld: 2330502
Request Sample
Customized Report
CRISPR Technology Market Size(US$)

CAGR 2024-2030
19.1%
Market Size,2030
USD 2,928.2
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for CRISPR Technology was estimated to be worth US$ 845 million in 2023 and is forecast to a readjusted size of US$ 2928.2 million by 2030 with a CAGR of 19.1% during the forecast period 2024-2030
North American market for CRISPR Technology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for CRISPR Technology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for CRISPR Technology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of CRISPR Technology include Thermo Fisher Scientific, Merck KGaA, GenScript, Integrated DNA Technologies (IDT), Horizon Discovery Group, Agilent Technologies, Cellecta, GeneCopoeia and New England Biolabs, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for CRISPR Technology, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of CRISPR Technology by region & country, by Type, and by Application.
The CRISPR Technology market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR Technology.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of CRISPR Technology manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of CRISPR Technology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of CRISPR Technology in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 CRISPR Technology Product Introduction
1.2 Global CRISPR Technology Market Size Forecast
1.3 CRISPR Technology Market Trends & Drivers
1.3.1 CRISPR Technology Industry Trends
1.3.2 CRISPR Technology Market Drivers & Opportunity
1.3.3 CRISPR Technology Market Challenges
1.3.4 CRISPR Technology Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global CRISPR Technology Players Revenue Ranking (2023)
2.2 Global CRISPR Technology Revenue by Company (2019-2024)
2.3 Key Companies CRISPR Technology Manufacturing Base Distribution and Headquarters
2.4 Key Companies CRISPR Technology Product Offered
2.5 Key Companies Time to Begin Mass Production of CRISPR Technology
2.6 CRISPR Technology Market Competitive Analysis
2.6.1 CRISPR Technology Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by CRISPR Technology Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR Technology as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 CRISPR Enzymes
3.1.2 CRISPR Libraries
3.1.3 CRISPR Kits
3.1.4 Others
3.2 Global CRISPR Technology Sales Value by Type
3.2.1 Global CRISPR Technology Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global CRISPR Technology Sales Value, by Type (2019-2030)
3.2.3 Global CRISPR Technology Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Biomedical
4.1.2 Agricultural
4.2 Global CRISPR Technology Sales Value by Application
4.2.1 Global CRISPR Technology Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global CRISPR Technology Sales Value, by Application (2019-2030)
4.2.3 Global CRISPR Technology Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global CRISPR Technology Sales Value by Region
5.1.1 Global CRISPR Technology Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global CRISPR Technology Sales Value by Region (2019-2024)
5.1.3 Global CRISPR Technology Sales Value by Region (2025-2030)
5.1.4 Global CRISPR Technology Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America CRISPR Technology Sales Value, 2019-2030
5.2.2 North America CRISPR Technology Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe CRISPR Technology Sales Value, 2019-2030
5.3.2 Europe CRISPR Technology Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific CRISPR Technology Sales Value, 2019-2030
5.4.2 Asia Pacific CRISPR Technology Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America CRISPR Technology Sales Value, 2019-2030
5.5.2 South America CRISPR Technology Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa CRISPR Technology Sales Value, 2019-2030
5.6.2 Middle East & Africa CRISPR Technology Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions CRISPR Technology Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions CRISPR Technology Sales Value
6.3 United States
6.3.1 United States CRISPR Technology Sales Value, 2019-2030
6.3.2 United States CRISPR Technology Sales Value by Type (%), 2023 VS 2030
6.3.3 United States CRISPR Technology Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe CRISPR Technology Sales Value, 2019-2030
6.4.2 Europe CRISPR Technology Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe CRISPR Technology Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China CRISPR Technology Sales Value, 2019-2030
6.5.2 China CRISPR Technology Sales Value by Type (%), 2023 VS 2030
6.5.3 China CRISPR Technology Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan CRISPR Technology Sales Value, 2019-2030
6.6.2 Japan CRISPR Technology Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan CRISPR Technology Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea CRISPR Technology Sales Value, 2019-2030
6.7.2 South Korea CRISPR Technology Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea CRISPR Technology Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia CRISPR Technology Sales Value, 2019-2030
6.8.2 Southeast Asia CRISPR Technology Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia CRISPR Technology Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India CRISPR Technology Sales Value, 2019-2030
6.9.2 India CRISPR Technology Sales Value by Type (%), 2023 VS 2030
6.9.3 India CRISPR Technology Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Profile
7.1.2 Thermo Fisher Scientific Main Business
7.1.3 Thermo Fisher Scientific CRISPR Technology Products, Services and Solutions
7.1.4 Thermo Fisher Scientific CRISPR Technology Revenue (US$ Million) & (2019-2024)
7.1.5 Thermo Fisher Scientific Recent Developments
7.2 Merck KGaA
7.2.1 Merck KGaA Profile
7.2.2 Merck KGaA Main Business
7.2.3 Merck KGaA CRISPR Technology Products, Services and Solutions
7.2.4 Merck KGaA CRISPR Technology Revenue (US$ Million) & (2019-2024)
7.2.5 Merck KGaA Recent Developments
7.3 GenScript
7.3.1 GenScript Profile
7.3.2 GenScript Main Business
7.3.3 GenScript CRISPR Technology Products, Services and Solutions
7.3.4 GenScript CRISPR Technology Revenue (US$ Million) & (2019-2024)
7.3.5 Integrated DNA Technologies (IDT) Recent Developments
7.4 Integrated DNA Technologies (IDT)
7.4.1 Integrated DNA Technologies (IDT) Profile
7.4.2 Integrated DNA Technologies (IDT) Main Business
7.4.3 Integrated DNA Technologies (IDT) CRISPR Technology Products, Services and Solutions
7.4.4 Integrated DNA Technologies (IDT) CRISPR Technology Revenue (US$ Million) & (2019-2024)
7.4.5 Integrated DNA Technologies (IDT) Recent Developments
7.5 Horizon Discovery Group
7.5.1 Horizon Discovery Group Profile
7.5.2 Horizon Discovery Group Main Business
7.5.3 Horizon Discovery Group CRISPR Technology Products, Services and Solutions
7.5.4 Horizon Discovery Group CRISPR Technology Revenue (US$ Million) & (2019-2024)
7.5.5 Horizon Discovery Group Recent Developments
7.6 Agilent Technologies
7.6.1 Agilent Technologies Profile
7.6.2 Agilent Technologies Main Business
7.6.3 Agilent Technologies CRISPR Technology Products, Services and Solutions
7.6.4 Agilent Technologies CRISPR Technology Revenue (US$ Million) & (2019-2024)
7.6.5 Agilent Technologies Recent Developments
7.7 Cellecta
7.7.1 Cellecta Profile
7.7.2 Cellecta Main Business
7.7.3 Cellecta CRISPR Technology Products, Services and Solutions
7.7.4 Cellecta CRISPR Technology Revenue (US$ Million) & (2019-2024)
7.7.5 Cellecta Recent Developments
7.8 GeneCopoeia
7.8.1 GeneCopoeia Profile
7.8.2 GeneCopoeia Main Business
7.8.3 GeneCopoeia CRISPR Technology Products, Services and Solutions
7.8.4 GeneCopoeia CRISPR Technology Revenue (US$ Million) & (2019-2024)
7.8.5 GeneCopoeia Recent Developments
7.9 New England Biolabs
7.9.1 New England Biolabs Profile
7.9.2 New England Biolabs Main Business
7.9.3 New England Biolabs CRISPR Technology Products, Services and Solutions
7.9.4 New England Biolabs CRISPR Technology Revenue (US$ Million) & (2019-2024)
7.9.5 New England Biolabs Recent Developments
7.10 Origene Technologies
7.10.1 Origene Technologies Profile
7.10.2 Origene Technologies Main Business
7.10.3 Origene Technologies CRISPR Technology Products, Services and Solutions
7.10.4 Origene Technologies CRISPR Technology Revenue (US$ Million) & (2019-2024)
7.10.5 Origene Technologies Recent Developments
7.11 Synthego Corporation
7.11.1 Synthego Corporation Profile
7.11.2 Synthego Corporation Main Business
7.11.3 Synthego Corporation CRISPR Technology Products, Services and Solutions
7.11.4 Synthego Corporation CRISPR Technology Revenue (US$ Million) & (2019-2024)
7.11.5 Synthego Corporation Recent Developments
7.12 Toolgen
7.12.1 Toolgen Profile
7.12.2 Toolgen Main Business
7.12.3 Toolgen CRISPR Technology Products, Services and Solutions
7.12.4 Toolgen CRISPR Technology Revenue (US$ Million) & (2019-2024)
7.12.5 Toolgen Recent Developments
8 Industry Chain Analysis
8.1 CRISPR Technology Industrial Chain
8.2 CRISPR Technology Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 CRISPR Technology Sales Model
8.5.2 Sales Channel
8.5.3 CRISPR Technology Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for CRISPR Technology was estimated to be worth US$ 1410 million in 2025 and is projected to reach US$ 4711 million, growing at a CAGR of 19.1% from 2026 to 2032.
Published Date: 2026-07-15
Pages: 112
USD 3950.00
(Single User License)
The global CRISPR Technology market was valued at US$ 1410 million in 2025 and is anticipated to reach US$ 4711 million by 2032, at a CAGR of 19.1% from 2026 to 2032.
Published Date: 2026-04-27
Pages: 113
USD 2900.00
(Single User License)
The global CRISPR Technology market size was US$ 1203 million in 2024 and is forecast to a readjusted size of US$ 4020 million by 2031 with a CAGR of 19.1% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 97
USD 4250.00
(Single User License)
The global market for CRISPR Technology was estimated to be worth US$ 1203 million in 2024 and is forecast to a readjusted size of US$ 4020 million by 2031 with a CAGR of 19.1% during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 101
USD 3950.00
(Single User License)
The global market for CRISPR Technology was valued at US$ 1203 million in the year 2024 and is projected to reach a revised size of US$ 4020 million by 2031, growing at a CAGR of 19.1% during the forecast period.
Published Date: 2025-02-27
Pages: 87
USD 2900.00
(Single User License)
Market Analysis and Insights: Global CRISPR Technology Market
Published Date: 2024-04-15
Pages: 109
USD 4900.00
(Single User License)
The global CRISPR Technology market was valued at US$ 845 million in 2023 and is anticipated to reach US$ 2928.2 million by 2030, witnessing a CAGR of 19.1% during the forecast period 2024-2030.
Published Date: 2024-01-04
Pages: 87
USD 2900.00
(Single User License)
The global market for CRISPR Technology was estimated to be worth US$ 1410 million in 2025 and is projected to reach US$ 4711 million, growing at a CAGR of 19.1% from 2026 to 2032.
Published: 2026-07-15
Pages: 112
The global CRISPR Technology market was valued at US$ 1410 million in 2025 and is anticipated to reach US$ 4711 million by 2032, at a CAGR of 19.1% from 2026 to 2032.
Published: 2026-04-27
Pages: 113
The global CRISPR Technology market size was US$ 1203 million in 2024 and is forecast to a readjusted size of US$ 4020 million by 2031 with a CAGR of 19.1% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 97
The global market for CRISPR Technology was estimated to be worth US$ 1203 million in 2024 and is forecast to a readjusted size of US$ 4020 million by 2031 with a CAGR of 19.1% during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 101
The global market for CRISPR Technology was valued at US$ 1203 million in the year 2024 and is projected to reach a revised size of US$ 4020 million by 2031, growing at a CAGR of 19.1% during the forecast period.
Published: 2025-02-27
Pages: 87
Market Analysis and Insights: Global CRISPR Technology Market
Published: 2024-04-15
Pages: 109
The global CRISPR Technology market was valued at US$ 845 million in 2023 and is anticipated to reach US$ 2928.2 million by 2030, witnessing a CAGR of 19.1% during the forecast period 2024-2030.
Published: 2024-01-04
Pages: 87
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now